contract Redline & negotiation
Looking to improve your contracting process, mitigate risk, and decrease start-up timelines? Enter your email below to get in contact with one of our experts at Elevate:
The Importance of Expert Review and Negotiation
Many research sites execute clinical trial agreements (CTAs) without performing a thorough review of contract terms and conditions. Their assumption is that most CROs/sponsors propose an agreement that is “fair and balanced” with respect to each party’s exposure. Unfortunately, some agreements place an undo burden on the site up to and including liability associated with the study drug.
For sites that review and negotiate agreements, the work is often performed by an individual that is not trained to perform this type of work. For smaller sites, the work often is performed by a research coordinator. For larger sites, the work may be completed by a lawyer or paralegal, but even those individuals oftentimes lack the domain expertise to evaluate language commonplace in clinical research CTAs. Instead of working exclusively on clinical research CTAs, they are tasked with reviewing all contracts for the institution.
Benefits of outsourcing contract negotiation
Outsourcing contract negotiation to a specialized provider like Elevate Clinical Research Solutions offers several key benefits:
Limiting Site Legal Exposure: By ensuring that agreements are meticulously reviewed and negotiated by experts who understand CTA-specific language, sites can avoid agreeing to terms that place unnecessary risk or responsibility on them. Expert review helps identify and mitigate potential liabilities, ensuring that agreements are balanced and that sites are only held accountable for aspects within their control.
Clarifying Contract Terms and Conditions: By thoroughly reviewing and negotiating the contract with expertise, research sites can ensure that all parties have a clear and mutual understanding of their responsibilities and expectations. This proactive approach helps prevent potential disagreements, facilitates better communication, and supports a more harmonious working relationship between the site and the sponsor, ultimately contributing to the successful execution of the clinical trial.
Reduce Study Start-Up Timelines: Finalizing the CTA is often the item which most delays the overall start-up timeline. By working with Elevate’s experts to create a playbook (or modify an existing playbook), sites are able to take into account best practices, industry trends, and site specific requirements. Most importantly, it is created to be useable for a variety of trial types/study considerations and with the aim of allowing for efficient negotiations. The initial setup work in addition to Elevate’s vast negotiation experience reduces the time needed to negotiate contracts.
How it works
1.
Contract playbook development
Elevate works with the site to develop a contract playbook outlining must haves verses nice to haves,as well as site specific requirements in way that will allow use for a variety of trial types and with an eye toward efficient negotiations.
2.
Study Documents Submission
The site sends CTA to Elevate for review.
3.
Contact redlining and negotiation
Elevate redlines the agreement and negotiates desired changes with the CRO/sponsor with client involvement customized to institutional process/preferences.
4.
CTA Finalization
Once the site and sponsor/CRO are in agreement, Elevate completes a final quality review and facilitates the signature process.
FAQ’S
-
Expert review of CTAs ensures that terms and conditions are clearly understood and negotiated to the site’s advantage. Experts can clarify complex language, identify potential liabilities, and negotiate favorable payment terms. This reduces the risk of misunderstandings, protects the site from undue exposure, and supports better cash flow management. Sites also benefit from Elevate's experiences with multiple sites as well as multiple sponsors/CROs to keep up with industry trends and finalize CTAs sooner.
-
Negotiating payment terms can improve cash flow by securing more favorable conditions, such as timely payments and appropriate reimbursement rates. This helps ensure that the site has sufficient funds to cover operational costs, reducing financial strain and supporting uninterrupted conduct of the clinical trial.
-
Executing CTAs without thorough review can lead to misunderstandings, financial strain, and legal liabilities. Sites may unknowingly accept terms that place undue responsibility on them, such as liability for the study drug, or face delayed payments that impact cash flow. A careful review helps avoid these pitfalls and ensures more favorable terms.
-
Yes, smaller research sites can greatly benefit from expert CTA review and negotiation services. These services can help level the playing field by ensuring that smaller sites receive fair compensation and avoid unfavorable terms that could otherwise strain their resources. Expert assistance helps protect their interests and supports their financial stability.
-
Negotiating favorable CTA terms can positively impact the overall success of a clinical trial by ensuring that the site is adequately compensated, liabilities are appropriately managed, and potential conflicts are minimized. This leads to a more efficient trial process, better site performance, and successful study outcomes.
About Elevate clinical research solutions
Elevate clinical research Solutions serves a wide range of clients, including Academic Medical Centers, Integrated Health Systems, Dedicated Research Sites, Multi-Specialty Practices, and Trial/Site Management Organizations. Our service offerings extend beyond contract redline and negotiation and includes Coverage Analysis, budget development and negotiation, revenue protection, CTMS builds, and research team staffing.
ready to learn more about our contract service?
Enter your email above to get into contact with one of our experts!